Genticel Secures EUR 18.2 Million (USD 23.7 million) in Capital Funding
Friday, April 26, 2013
Dr. Rainer Strohmenger joins the supervisory board of Genticel.
Ipsen Expects Increlex® Supply Interruption Due to Supplier Manufacturing Issues
Friday, April 26, 2013
The Group reiterates 2013 financial guidance.
Alexion Broadens and Strengthens its Executive Leadership Team
Friday, April 26, 2013
Company has expanding global mission to develop and commercialize life transforming therapies for patients with disorders that are severe, life-threatening, and ultra-rare.
Emergent BioSolutions to Acquire Healthcare Protective Products Division of Bracco Diagnostics Inc.
Friday, April 26, 2013
The acquisition will diversify and expand Emergent’s biodefense franchise.
Why Does Smallpox Vaccine Shield Some, Not Others? It's in the Genes
Tuesday, April 23, 2013
How well people are protected by the smallpox vaccine depends on more than the quality of the vaccination: individual genes can alter their response, Mayo Clinic research shows.
Vaccine Experts Offer Solutions to Support Vaccine Innovation, Access
Tuesday, April 23, 2013
Peer-reviewed article in Vaccine offers actions for bringing vaccines to 90% of the world.
Fujifilm Diosynth Biotechnologies Commissions New Cell Banking Facility
Monday, April 22, 2013
Fujifilm Diosynth Biotechnologies has commissioned on time its new mammalian cGMP Cell Banking Facility (CBF) at its Billingham, UK site.
DSM Announces Opening of New cGMP Biopharmaceutical Manufacturing Operation
Monday, April 22, 2013
Company announced that their new cGMP custom biopharmaceutical manufacturing 'biologics plant of the future' will open in Brisbane, Australia, in June 2013.
DSM and DecImmune Therapeutics Sign Agreement
Monday, April 22, 2013
Agreement to develop N2 pathway blocking antibody.
|
|
|
|
|
|
